Physician profile
John E Tobey
NPI 1013902352
$701.52
in general payments reported to CMS, 2019-2025
12 companies · $245 in 2025
The $245 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $51.65 · 2022: $106 · 2023: $115 · 2024: $183 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $543.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $204.26 | 2022-2025 | Botox |
| Pacira Pharmaceuticals Incorporated | $121.26 | 2023-2025 | Iovera, Zilretta |
| Abbott Laboratories | $101.25 | 2021-2024 | Proclaim |
| Boston Scientific Corporation | $79.74 | 2024-2025 | Wavewriter Alpha Prime 16, Na |
| Trice Medical, INC. | $48.58 | 2025 | |
| Merz Pharmaceuticals, LLC | $31.64 | 2025 | Xeomin |
| Gemini Mountain Medical, LLC | $24.65 | 2025 | |
| Ferring Pharmaceuticals INC. | $22.87 | 2022 | |
| Siemens Medical Solutions USA, INC. | $17.78 | 2022 | |
| Depuy Synthes Sales INC. | $17.59 | 2024 | Orthovisc, Monovisc |
| Avanos Medical | $16.71 | 2024 | Genvisc 850 Sodium Hyaluronate |
| Bioventus LLC | $15.19 | 2024 | Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Tobey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.